-
Digital hijack – the hidden agenda of Big Tech and what to do about it
09 January 2019
Confused science on screen abuse and how Silicon Valley techies are trying to redress the balance
News / Good Science / Health / Activism
-
News Alerts: Week 31, 2018
01 August 2018
NHS and Brexit; Hide and seek with nuclear waste; Supplements under attack in US; Australia ‘no jab, no pay’ pain; Smart meters to hit UK wallets; Brazilians poisoned by pesticides; Food additives and children’s health
-
News Alerts: Week 25, 2018
20 June 2018
Monsanto; Triclosan; HPV vaccine; Alzheimer’s disease; Sugar labelling; Disappearing insects; US Teens & alternative medicine; Drugs & Depression
-
Food4Health Campaign
Confused by what government’s are saying we should be eating? You’re not alone! Government guidelines are based on outdated or flawed science. Worse, they’re contributing to making people sick, fat and tired. Find out more about what healthy eating is really all about.
-
Want a quick fix for weight loss this January?
12 January 2024
In-house ANH nutrition practitioners, Meleni Aldridge and Melissa Smith, take you on a journey through the options, from gastric bands to semaglutide injections, then showing you why natural approaches targeting metabolic flexibility are best
-
ANH News Beat (week 46/2023)
15 November 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 29/2023)
20 July 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 25/2023)
21 June 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 22/2023)
31 May 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Are you up for taking Big Pharma's new 'skinny' jab?
16 March 2023
After a succession of Big Pharma failures for anti-obesity drugs, will Novo Nordisk's latest offering, that emerges from something of a dark cloud, be just another side effect ladened sticking plaster, or a boon for users and a cash cow for its manufacturer?